Enforcement record

Recommendation disclosure naming 欧州ビジネス協会（EBC）

欧州ビジネス協会（EBC） (Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices)

This page records one action from a Japanese government disclosure, including the published name, governing law, authority, action details, and official source.

Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical DevicesMinistry of Health, Labour and WelfareGovernment disclosure14 September 2023

Action type

Recommendation

Law

Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices

Authority

Ministry of Health, Labour and Welfare

Action date

14 September 2023

Current page: Enforcement record

This screen focuses on one disclosed action: the published name, governing law, authority, facts, source status, and review evidence.

Source verification

Public-source and preservation status

Publishing authority: Ministry of Health, Labour and Welfare
Official source URL: Recorded by RegBase
Entity match: Not confirmed; shown under the published name
Kiroku preservation: Completed archive verified; Captured: Jun 14, 2026, 03:33 PM JST

“Confirmed” means that RegBase matched this record to the cited public disclosure or entity under the stated checks. It does not verify the truth of the disclosure or guarantee the entity’s current status, creditworthiness, or any legal conclusion.

Open the official source links in the section below to review the original disclosure.

Action summary

Company: 欧州ビジネス協会（EBC）Japanese only
Original: 欧州ビジネス協会（EBC）
Governing law: Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices
薬機法
Action type: Recommendation
勧告
Action date: 14 September 2023
Issuing authority: Ministry of Health, Labour and Welfare
厚生労働省
Industry context: 医療機器国際規制

Violation

Machine-translated summary — verify against original

Exchange of opinions regarding the promotion of international integration and the referencing of countries.

Show original Japanese text

国際整合の推進とリファレンスカントリー化に関する意見交換

Compliance context

Medium

A regulator issued a recommendation or formal request for corrective action.

Health product law covering pharmaceuticals, medical devices, cosmetics, quasi-drugs, labeling, and advertising.

Review the facts and follow-up status. This is usually less severe than a suspension or revocation, but still a public enforcement signal.

This context is an operational aid for review workflows, not a credit opinion or legal conclusion.

Open original sources and verification detailsOfficial URL, direct PDF, and Kiroku archive

Original Ministry of Health, Labour and Welfare source (Japanese)Open preserved source and evidence pack

Extracted at: 2026-04-25T00:26:45.964+00:00
Evidence checked: 2026-04-25T00:26:45.964+00:00
Archive captured: 2026-06-14T06:33:43.074199+00:00

Show audit JSON

{
  "record": {
    "id": "1cc522d5-a205-4634-a298-99ba9b914fd1",
    "url": "https://regbase.jp/en/enforcement/yakkiho-ou-zhou-bizinesuxie-huiebc-20230914",
    "company_name_original": "欧州ビジネス協会（EBC）",
    "company_name_registry": null,
    "corporate_number": null,
    "law": {
      "ja": "薬機法",
      "en": "Act on Securing Quality, Efficacy and Safety of Pharmaceuticals and Medical Devices"
    },
    "action_type": {
      "ja": "勧告",
      "en": "Recommendation"
    },
    "authority": {
      "ja": "厚生労働省",
      "en": "Ministry of Health, Labour and Welfare"
    }
  },
  "entity_match": {
    "status": "unresolved",
    "confidence": 60,
    "method": "extracted_japanese_name",
    "method_label": "Company name extracted from the Japanese public disclosure",
    "notes": "The linked company profile has not been verified under the current identity policy."
  },
  "review": {
    "status": "unreviewed",
    "label": "Machine extracted"
  },
  "compliance_context": {
    "severity": "Medium",
    "actionMeaning": "A regulator issued a recommendation or formal request for corrective action.",
    "practicalNote": "Review the facts and follow-up status. This is usually less severe than a suspension or revocation, but still a public enforcement signal.",
    "lawContext": "Health product law covering pharmaceuticals, medical devices, cosmetics, quasi-drugs, labeling, and advertising."
  },
  "evidence": {
    "recordUrl": "https://regbase.jp/en/enforcement/yakkiho-ou-zhou-bizinesuxie-huiebc-20230914",
    "officialSourceUrl": "https://www.mhlw.go.jp/stf/newpage_35771.html",
    "officialDocumentUrl": null,
    "archiveUrl": "https://kiroku.today/a/7547e0e12adenpzu",
    "archivedSourceUrl": "https://www.mhlw.go.jp/stf/newpage_35771.html",
    "archiveCapturedAt": "2026-06-14T06:33:43.074199+00:00",
    "extractedAt": "2026-04-25T00:26:45.964+00:00",
    "translatedAt": "2026-05-01T07:14:39.633+00:00",
    "evidenceCheckedAt": "2026-04-25T00:26:45.964+00:00",
    "generatedAt": "2026-09-18T20:03:58.317Z"
  },
  "limitations": [
    "RegBase aggregates public Japanese government disclosures and does not provide a credit opinion.",
    "English summaries are provided for reference. The original Japanese source is authoritative.",
    "Possible or unresolved entity matches should be manually verified before use in a decision."
  ]
}

The original Japanese disclosure is the authoritative record. Use possible or unresolved matches only as leads for manual review.

Language

日本語版を見る (Japanese)

About this recordAggregated and translated from public Japanese government disclosures. The English text is for reference only — authoritative content is the linked Japanese source.